Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Conversion From CNI to Everolimus After Kidney Transplant

Published: Wed, 16 Aug 2017 12:00:00 EDT
What benefits may converting from conventional CNI therapy to everolimus-based therapy offer kidney transplant patients?
American Journal of Transplantation

Assessment of Liver Fibrosis in Patients With Chronic HBV

Published: Wed, 16 Aug 2017 12:00:00 EDT
The authors compared the diagnostic performance of several biomarkers for the assessment of liver fibrosis in patients with chronic HBV infection.
Journal of Viral Hepatitis

Guidance for Pregnant Women With Possible Zika Virus Exposure

Published: Wed, 16 Aug 2017 12:00:00 EDT
Based on the latest trends and evidence, CDC has slightly revised its guidance for U.S. health care providers caring for pregnant women with possible Zika virus exposure.
Morbidity & Mortality Weekly Report

Age and Differences in Antihypertensive Adherence in Hispanics

Published: Wed, 16 Aug 2017 12:00:00 EDT
Hispanics have a higher prevalence of uncontrolled hypertension than do people of other racial/ethnic groups. Does poor adherence play a significant role, and does it differ by age group?
Preventing Chronic Disease
Displaying results 5-8 (of 20)
 1 - 2 - 3 - 4 - 5 

HEALTHCARE SUPPLIER NEWS

Cerecor CEO retires after scoring Johnson & Johnson license deal

Published: Tue, 15 Aug 2017 12:38:52 +0000
Shares in Cerecor leaped after the biotech licensed an antidepressant candidate to Johnson & Johnson, bringing in additional cash to advance its pipeline. The cash injection gives the Baltimore-based biotech operating cash through at least 2018.

ROS1 cancer patients set out to create disease models

Published: Tue, 15 Aug 2017 12:27:23 +0000
A group of cancer patients with the ROS1 mutation has teamed up with a nonprofit and a precision medicine company to create disease models. The collaboration aims to drive forward research into treatments for the rare ROS1 gene mutation by gathering tissue samples from patients.

China’s HitGen bags new drug discovery deal with Aduro

Published: Mon, 14 Aug 2017 20:50:30 +0000
Following drug discovery collaborations with big pharma companies Merck & Co., Johnson & Johnson and Pfizer, DNA-encoded library technology expert HitGen just inked another multiyear, multitarget deal with Aduro Biotech.

News of Note—Zynerba repeat failure, Fortress spinoff, CEL-SCI lift and more

Published: Mon, 14 Aug 2017 13:41:03 +0000
Monday's dose of additional news of note from around the biopharma world.
Displaying results 5-8 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top